ARIA; Information and communications technology; MACVIA-LR; allergic rhinitis; asthma
Résumé :
[en] Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient empowerment. MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergic rhinitis and its asthma comorbidity (ARIA 2015 revision). It is one of the implementation systems of Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Three tools are used for the electronic monitoring of allergic diseases: a cell phone-based daily visual analogue scale (VAS) assessment of disease control, CARAT (Control of Allergic Rhinitis and Asthma Test) and e-Allergy screening (premedical system of early diagnosis of allergy and asthma based on online tools). These tools are combined with a clinical decision support system (CDSS) and are available in many languages. An e-CRF and an e-learning tool complete MASK. MASK is flexible and other tools can be added. It appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards.
Disciplines :
Systèmes cardiovasculaire & respiratoire
Auteur, co-auteur :
Bousquet, J.
Schunemann, H. J.
Fonseca, J.
Samolinski, B.
Bachert, C.
Canonica, G. W.
Casale, T.
Cruz, A. A.
Demoly, P.
Hellings, P.
Valiulis, A.
Wickman, M.
Zuberbier, T.
Bosnic-Anticevitch, S.
Bedbrook, A.
Bergmann, K. C.
Caimmi, D.
Dahl, R.
Fokkens, W. J.
Grisle, I.
Lodrup Carlsen, K.
Mullol, J.
Muraro, A.
Palkonen, S.
Papadopoulos, N.
Passalacqua, G.
Ryan, D.
Valovirta, E.
Yorgancioglu, A.
Aberer, W.
Agache, I.
Adachi, M.
Akdis, C. A.
Akdis, M.
Annesi-Maesano, I.
Ansotegui, I. J.
Anto, J. M.
Arnavielhe, S.
Arshad, H.
Baiardini, I.
Baigenzhin, A. K.
Barbara, C.
Bateman, E. D.
Beghe, B.
Bel, E. H.
Ben Kheder, A.
Bennoor, K. S.
Benson, M.
Bewick, M.
Bieber, T.
Bindslev-Jensen, C.
Bjermer, L.
Blain, H.
Boner, A. L.
Boulet, L. P.
Bonini, M.
Bonini, S.
Bosse, I.
Bourret, R.
Bousquet, P. J.
Braido, F.
Briggs, A. H.
Brightling, C. E.
Brozek, J.
Buhl, R.
Burney, P. G.
Bush, A.
Caballero-Fonseca, F.
Calderon, M. A.
Camargos, P. A. M.
Camuzat, T.
Carlsen, K. H.
Carr, W.
Cepeda Sarabia, A. M.
Chavannes, N. H.
Chatzi, L.
Chen, Yu ; Université de Liège > Département de pharmacie > Chimie médicale
Chiron, R.
Chkhartishvili, E.
Chuchalin, A. G.
Ciprandi, G.
Cirule, I.
Correia de Sousa, J.
Cox, L.
Crooks, G.
Costa, D. J.
Custovic, A.
Dahlen, S. E.
Darsow, U.
De Carlo, G.
De Blay, F.
Dedeu, T.
Deleanu, D.
Denburg, J. A.
Devillier, P.
Didier, A.
Dinh-Xuan, A. T.
Dokic, D.
Douagui, H.
Dray, G.
Dubakiene, R.
Durham, S. R.
Dykewicz, M. S.
El-Gamal, Y.
Emuzyte, R.
Fink Wagner, A.
Fletcher, M.
Fiocchi, A.
Forastiere, F.
Gamkrelidze, A.
Gemicioglu, B.
Gereda, J. E.
Gonzalez Diaz, S.
Gotua, M.
Grouse, L.
Guzman, M. A.
Haahtela, T.
Hellquist-Dahl, B.
Heinrich, J.
Horak, F.
Hourihane, J. O. B
Howarth, P.
Humbert, M.
Hyland, M. E.
Ivancevich, J. C.
Jares, E. J.
Johnston, S. L.
Joos, G.
Jonquet, O.
Jung, K. S.
Just, J.
Kaidashev, I.
Kalayci, O.
Kalyoncu, A. F.
Keil, T.
Keith, P. K.
Khaltaev, N.
Klimek, L.
Koffi N'Goran, B.
Kolek, V.
Koppelman, G. H.
Kowalski, M. L.
Kull, I.
Kuna, P.
Kvedariene, V.
Lambrecht, B.
Lau, S.
Larenas-Linnemann, D.
Laune, D.
Le, L. T. T.
Lieberman, P.
Lipworth, B.
Li, J.
LOUIS, Renaud ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie
Magard, Y.
Magnan, A.
Mahboub, B.
Majer, I.
Makela, M. J.
Manning, P.
De Manuel Keenoy, E.
Marshall, G. D.
Masjedi, M. R.
Maurer, M.
Mavale-Manuel, S.
Melen, E.
Melo-Gomes, E.
Meltzer, E. O.
Merk, H.
Miculinic, N.
Mihaltan, F.
Milenkovic, B.
Mohammad, Y.
Molimard, M.
Momas, I.
Montilla-Santana, A.
Morais-Almeida, M.
Mosges, R.
Namazova-Baranova, L.
Naclerio, R.
Neou, A.
Neffen, H.
Nekam, K.
Niggemann, B.
Nyembue, T. D.
O'Hehir, R. E.
Ohta, K.
Okamoto, Y.
Okubo, K.
Ouedraogo, S.
Paggiaro, P.
Pali-Scholl, I.
Palmer, S.
Panzner, P.
Papi, A.
Park, H. S.
Pavord, I.
Pawankar, R.
Pfaar, O.
Picard, R.
Pigearias, B.
Pin, I.
Plavec, D.
Pohl, W.
Popov, T. A.
Portejoie, F.
Postma, D.
Potter, P.
Price, D.
Rabe, K. F.
Raciborski, F.
Radier Pontal, F.
Repka-Ramirez, S.
Robalo-Cordeiro, C.
Rolland, C.
Rosado-Pinto, J.
Reitamo, S.
Rodenas, F.
Roman Rodriguez, M.
Romano, A.
Rosario, N.
Rosenwasser, L.
Rottem, M.
Sanchez-Borges, M.
Scadding, G. K.
Serrano, E.
Schmid-Grendelmeier, P.
Sheikh, A.
Simons, F. E. R.
Sisul, J. C.
Skrindo, I.
Smit, H. A.
Sole, D.
Sooronbaev, T.
Spranger, O.
Stelmach, R.
Strandberg, T.
Sunyer, J.
Thijs, C.
Todo-Bom, A.
Triggiani, M.
Valenta, R.
Valero, A. L.
van Hage, M.
Vandenplas, O.
Vezzani, G.
Vichyanond, P.
Viegi, G.
Wagenmann, M.
Walker, S.
Wang, D. Y.
Wahn, U.
Williams, D. M.
Wright, J.
Yawn, B. P.
Yiallouros, P. K.
Yusuf, O. M.
Zar, H. J.
Zernotti, M. E.
Zhang, Lihong ; Université de Liège > Département ArGEnCo > Adéquat. struct. aux exig. de fonct.& perfor. techn.-écon.
Bousquet J, Khaltaev N,. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. Geneva, Switzerland: World Health Organization. ISBN 978 92 4 156346 8. 2007: 148.
Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A, et al., Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol 2015; 135: 1199-1206.
Bousquet J, Anto JM, Berkouk K, Gergen P, Pinto AJ, Auge P, et al., Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015; 70: 595-597.
Bousquet J, Gern JE, Martinez FD, Anto JM, Johnson CC, Holt PG, et al., Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol 2014; 133: 1535-1546.
Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK,. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 2014; 69: 1275-1279.
Bousquet J, Van CP, Khaltaev N,. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 5 (Suppl): S147-S334.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl 86): 8-160.
Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A,. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007; 120: 381-387.
Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J,. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012; 379: e45-e46.
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al., Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012; 130: 1049-1062.
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M,. The european innovation partnership on active and healthy ageing: the european geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med 2014; 5: 361-362.
Bousquet J, Hajjam J, Piette F, Jean-Bart B, Wlosik C, Robine JM, et al., The French reference sites of the European Innovation Partnership on active and healthy ageing. Presse Med 2013; 42: 1558-1561.
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al., Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014; 44: 304-323.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al., European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012; 23: 3-p.
Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al., Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009; 124: 428-433.
Bousquet PJ, Bachert C, Canonica GW, Casale TB, Mullol J, Klossek JM, et al., Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 2010; 126: 666-668.
Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz dLD, et al., Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2013; 68: 1-7.
Marsh D, Dechamp C, Cour P, Bousquet J, Deviller P,. Correlation between the atmospheric level of antigen Amb-al (AgE) and the number of Ambrosia artemisiaefolia pollen grains in Lyon and neighboring regions. Allerg Immunol (Paris) 1987; 1: 43.
Buters JT, Weichenmeier I, Ochs S, Pusch G, Kreyling W, Boere AJ, et al., The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts. Allergy. 2010; 65: 850-858.
Agarwal MK, Swanson MC, Reed CE, Yunginger JW,. Airborne ragweed allergens: association with various particle sizes and short ragweed plant parts. J Allergy Clin Immunol 1984; 74: 687-693.
Frenz DA,. Interpreting atmospheric pollen counts for use in clinical allergy: spatial variability. Ann Allergy Asthma Immunol 2000; 84: 481-489.
Caillaud DM, Martin S, Segala C, Vidal P, Lecadet J, Pellier S, et al., Airborne pollen levels and drug consumption for seasonal allergic rhinoconjunctivitis: a 10-year study in France. Allergy 2015; 70: 99-106.
Galan C, Antunes C, Brandao R, Torres C, Garcia-Mozo H, Caeiro E, et al., Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1. Allergy 2013; 68: 809-812.
Frenguelli G, Passalacqua G, Bonini S, Fiocchi A, Incorvaia C, Marcucci F, et al., Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology. Ann Allergy Asthma Immunol 2010; 105: 223-227.
Caillaud D, Martin S, Segala C, Besancenot JP, Clot B, Thibaudon M,. Effects of airborne birch pollen levels on clinical symptoms of seasonal allergic rhinoconjunctivitis. Int Arch Allergy Immunol 2014; 163: 43-50.
Caillaud DM, Martin S, Segala C, Besancenot JP, Clot B, Thibaudon M,. Nonlinear short-term effects of airborne Poaceae levels on hay fever symptoms. J Allergy Clin Immunol 2012; 130: 812-814.
Annesi-Maesano I, Rouve S, Desqueyroux H, Jankovski R, Klossek JM, Thibaudon M, et al., Grass pollen counts, air pollution levels and allergic rhinitis severity. Int Arch Allergy Immunol 2012; 158: 397-404.
Lubitz S, Schober W, Pusch G, Effner R, Klopp N, Behrendt H, et al., Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils. Environ Toxicol 2010; 25: 188-197.
Boehm G, Leuschner RM,. Experiences with the 'Individual Pollen Collector' developed by G. Boehm. Experientia Suppl 1987; 51: 87-88.
Agarwal MK, Swanson MC, Reed CE, Yunginger JW,. Immunochemical quantitation of airborne short ragweed, Alternaria, antigen E, and Alt-I allergens: a two-year prospective study. J Allergy Clin Immunol 1983; 72: 40-45.
Longhi S, Cristofori A, Gatto P, Cristofolini F, Grando MS, Gottardini E,. Biomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring? Ann Allergy Asthma Immunol 2009; 103: 508-514.
Cassagne E, Caillaud PD, Besancenot JP, Thibaudon M,. Forecasting the onset of an allergic risk to poaceae in Nancy and Strasbourg (France) with different methods. Eur Ann Allergy Immunol 2007; 39: 262-268.
Estrella N, Menzel A, Kramer U, Behrendt H,. Integration of flowering dates in phenology and pollen counts in aerobiology: analysis of their spatial and temporal coherence in Germany (1992-1999). Int J Biometeorl 2006; 51: 49-59.
Laaidi K,. Predicting days of high allergenic risk during Betula pollination using weather types. Int J Biometeorl 2001; 45: 124-132.
Myszkowska D, Majewska R,. Pollen grains as allergenic environmental factors-new approach to the forecasting of the pollen concentration during the season. AAEM 2014; 21: 681-688.
Voukantsis D, Berger U, Tzima F, Karatzas K, Jaeger S, Bergmann KC,. Personalized symptoms forecasting for pollen-induced allergic rhinitis sufferers. Int J Biometeorl. 2015; 59: 889-897.
de Weger LA, Beerthuizen T, Hiemstra PS, Sont JK,. Development and validation of a 5-day-ahead hay fever forecast for patients with grass-pollen-induced allergic rhinitis. Int J Biometeorl 2014; 58: 1047-1055.
Nuti SV, Wayda B, Ranasinghe I, Wang S, Dreyer RP, Chen SI, et al., The use of google trends in health care research: a systematic review. PLoS ONE 2014; 9: e109583.
Broniatowski DA, Paul MJ, Dredze M,. National and local influenza surveillance through Twitter: an analysis of the 2012-2013 influenza epidemic. PLoS ONE 2013; 8: e83672.
Bernardo TM, Rajic A, Young I, Robiadek K, Pham MT, Funk JA,. Scoping review on search queries and social media for disease surveillance: a chronology of innovation. J Med Internet Res 2013; 15: e147.
Mosges R, Adrian M, El HE, Konig V,. What Google(R) knows about the pollen season. Allergy 2011; 66: 707-708.
Dugas AF, Jalalpour M, Gel Y, Levin S, Torcaso F, Igusa T, et al., Influenza forecasting with Google Flu Trends. PLoS ONE 2013; 8: e56176.
Konig V, Mosges R,. A model for the determination of pollen count using google search queries for patients suffering from allergic rhinitis. J Allergy 2014; 2014: 381983.
Berger U, Kmenta M, Bastl K,. Individual pollen exposure measurements: are they feasible? Curr Opin Allergy Clinical Immunol 2014; 14: 200-205.
Kmenta M, Bastl K, Jager S, Berger U,. Development of personal pollen information-the next generation of pollen information and a step forward for hay fever sufferers. Int J Biometeorl 2014; 58: 1721-1726.
Lahdensuo A, Haahtela T, Herrala J, Kava T, Kiviranta K, Kuusisto P, et al., Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 1996; 312: 748-752.
Lahdensuo A, Haahtela T, Herrala J, Kava T, Kiviranta K, Kuusisto P, et al., Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ 1998; 316: 1138-1139.
Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al., A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
von Hertzen LC, Savolainen J, Hannuksela M, Klaukka T, Lauerma A, Makela MJ, et al., Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance. Allergy 2009; 64: 678-701.
Haahtela T, von Hertzen L, Makela M, Hannuksela M,. Finnish Allergy Programme 2008-2018-time to act and change the course. Allergy 2008; 63: 634-645.
Deliu M, Belgrave D, Simpson A, Murray CS, Kerry G, Custovic A,. Impact of rhinitis on asthma severity in school-age children. Allergy 2014; 69: 1515-1521.
Campbell H, Hotchkiss R, Bradshaw N, Porteous M,. Integrated care pathways. BMJ 1998; 316: 133-137.
Overill S,. A practical guide to care pathways. J Integr Care 1998; 2: 93-98.
Integrated Care Pathways users in Scotland (ICPUS). A workbook for people starting to develop integrated care pathways. http://www.icpus.org.uk2007.
How to produce and evaluate an integrated care pathway (ICP): information for staff. Great Ormond Street Hospital for Children. wwwgoshnhsuk. 2010.
Bruhn S, Fang Y, Barrenas F, Gustafsson M, Zhang H, Konstantinell A, et al., A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy. Sci Translat Med 2014; 6: 218ra4.
Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ,. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137: 1410-1416.
Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al., MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596-604.
Anto JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagana X, et al., Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol 2012; 129: 943-954.
Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al., Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2014; 66: 106-119.
Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, et al., Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011; 3: 43.
Skrindo I, Lupinek C, Valenta R, Hovland V, Pahr S, Baar A, et al., The use of the MeDALL-chip to assess IgE sensitization, a new diagnostic tool for allergic disease? Pediatr Allergy Immunol 2015; 26: 239-246.
Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, et al., Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010; 65: 290-295.
Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, et al., Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014; 69: 854-867.
Ayres JG, Forsberg B, Annesi-Maesano I, Dey R, Ebi KL, Helms PJ, et al., Climate change and respiratory disease: European Respiratory Society position statement. Eur Respir J 2009; 34: 295-302.
D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H, et al., Allergenic pollen and pollen allergy in Europe. Allergy 2007; 62: 976-990.
Haahtela T,. Allergy is rare where butterflies flourish in a biodiverse environment. Allergy 2009; 64: 1799-1803.
Members of the Workshops. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy 2004; 59: 373-387.
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
Valero A, Ferrer M, Baro E, Sastre J, Navarro AM, Marti-Guadano E, et al., Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy 2010; 65: 1609-1613.
Montoro J, Del CA, Mullol J, Molina X, Bartra J, Davila I, et al., Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study. Allergy 2012; 67: 1437-1442.
Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, et al., Severe chronic allergic (and related) diseases: a uniform approach-a MeDALL-GA2LEN-ARIA position paper. Int Arch Allergy Immunol 2012; 158: 216-231.
Expert panel report 3: Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program. National Heart, Lung and Blood Institute. US Department of Health and Human Services. 440 pages. 2007.
Vestbo J, Rennard S,. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. Am J Respir Crit Care Med 2010; 182: 863-864.
Vijan S,. Type 2 diabetes. Ann Intern Med 2010; 152: ITC31-15.
Bousquet PJ, Bousquet-Rouanet L, Co Minh HB, Urbinelli R, Allaert FA, Demoly P,. ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France. Int Arch Allergy Immunol 2007; 143: 163-169.
Di Lorenzo G, Pacor ML, Amodio E, Leto-Barone MS, La Piana S, D'Alcamo A, et al., Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol 2011; 155: 263-270.
Lu D, Zhao Y, Zheng Y, An P, Wang L, Qiao X, et al., Evaluation of quality of life questionnaires for adult patients with moderate to severe allergic rhinitis. Am J Otolaryngol 2011; 32: 494-498.
del Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al., Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients-The ADRIAL cohort study. Rhinology 2010; 48: 201-205.
Demoly P, Jankowski R, Chassany O, Bessah Y, Allaert FA,. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy 2011; 41: 860-868.
Ohta K, Bousquet PJ, Aizawa H, Akiyama K, Adachi M, Ichinose M, et al., Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan. Allergy 2011; 66: 1287-1295.
Ragab SM, Lund VJ, Saleh HA, Scadding G,. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy 2006; 61: 717-724.
Valero A, Ferrer M, Sastre J, Navarro AM, Monclus L, Marti-Guadano E, et al., A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol 2007; 120: 359-365.
Schatz M, Meltzer EO, Nathan R, Derebery MJ, Mintz M, Stanford RH, et al., Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 2010; 104: 118-124.
Devillier P, Chassany O, Vicaut E, de Beaumont O, Robin B, Dreyfus JF, et al., The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis. Allergy 2014; 69: 1689-1695.
Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, et al., A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 1999; 116: 1208-1217.
Pfennings L, Cohen L, van der Ploeg H,. Preconditions for sensitivity in measuring change: visual analogue scales compared to rating scales in a Likert format. Psychol Rep 1995; 77: 475-480.
Bousquet PJ, Combescure C, Klossek JM, Daures JP, Bousquet J,. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol 2009; 123: 1349-1354.
Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt S, Palkonen S, et al., Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 2008; 63: 981-989.
Morais-Almeida M, Santos N, Pereira AM, Branco-Ferreira M, Nunes C, Bousquet J, et al., Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. Allergy 2013; 68: 1278-1288.
Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al., Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy 2013; 68: 1150-1157.
Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev JC, et al., Efficacy of desloratadine in intermittent allergic rhinitis: a GALEN study. Allergy 2009; 64: 1516-1523.
Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Jensen CB, et al., Efficacy of desloratadine in persistent allergic rhinitis-a GA(2)LEN study. Int Arch Allergy Immunol 2010; 153: 395-402.
Larenas-Linnemann D, Dinger H, Shah-Hosseini K, Michels A, Mosges R,. Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico. Am J Rhinol Allergy 2013; 27: 495-501.
Shao J, Cui YX, Zheng YF, Peng HF, Zheng ZL, Chen JY, et al., Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis. Am J Rhinol Allergy 2014; 28: 131-139.
Wei H, Zhang Y, Shi L, Zhang J, Xia Y, Zang J, et al., Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis. Int J Med Sci 2013; 10: 1914-1920.
Tatar EC, Surenoglu UA, Saylam G, Isik E, Ozdek A, Korkmaz H,. Is there any correlation between the results of skin-prick test and the severity of symptoms in allergic rhinitis? Am J Rhinol Allergy 2012; 26: e37-e39.
Rouve S, Didier A, Demoly P, Jankowsky R, Klossek JM, Anessi-Maesano I,. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity. Rhinology 2010; 48: 285-291.
Baiardini I, Braido F, Brandi S, Tarantini F, Bonini S, Bousquet PJ, et al., The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. Allergy 2008; 63: 1015-1030.
Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J,. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 2013; 160: 393-400.
Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, et al., Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc 2012; 33: e17-e22.
Bousquet J, Lund VJ, Van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT, et al., Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003; 58: 733-741.
Bousquet J, Bodez T, Gehano P, Klossek JM, Liard F, Neukirch F, et al., Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol 2009; 150: 75-82.
Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P,. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy 2013; 43: 881-888.
Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D,. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis. J Biol Regul Homeost Agents 2009; 23: 31-36.
Davies RJ, Lund VJ, Harten-Ash VJ,. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159-164.
Henauer S, Hugonot L, Hugonot R, Kurzeja A, Gastpar H, Rauch-Riedelsheimer B, et al., Multi-centre double-blind comparison of terfenadine once daily versus twice daily in patients with hay fever. J Int Med Res 1987; 15: 212-223.
Newson-Smith G, Powell M, Baehre M, Garnham SP, MacMahon MT,. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol 1997; 254: 236-241.
Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al., Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
Samolinski B, Sybilski AJ, Raciborski F, Tomaszewska A, Samel-Kowalik P, Walkiewicz A, et al., Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study. Otolaryngol Pol. 2009; 63: 324-330.
Klimek L, Bachert C, Mosges R, Munzel U, Price D, Virchow JC, et al., Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc 2015; 36: 40-47.
Azevedo P, Correia dSJ, Bousquet J, Bugalho-Almeida A, Del GS, Demoly P, et al., Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J. 2013; 22: 112-116.
Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M, et al., Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010; 65: 1042-1048.
Nogueira-Silva L, Martins SV, Cruz-Correia R, Azevedo LF, Morais-Almeida M, Bugalho-Almeida A, et al., Control of allergic rhinitis and asthma test-a formal approach to the development of a measuring tool. Respir Res 2009; 10: 52.
van der Leeuw S, van der Molen T, Dekhuijzen PN, Fonseca JA, van Gemert FA, Gerth van Wijk R, et al., The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med 2015; 25: 14107.
Lourenco O, Calado S, Sa-Sousa A, Fonseca J,. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Managed care Special Pharm 2014; 20: 513-522.
Borrego LM, Fonseca JA, Pereira AM, Pinto VR, Linhares D, Morais-Almeida M,. Development process and cognitive testing of CARATkids-Control of Allergic Rhinitis and Asthma Test for children. BMC Pediatr 2014; 14: 34.
Linhares DV, da Fonseca JA, Borrego LM, Matos A, Pereira AM, Sa-Sousa A, et al., Validation of control of allergic rhinitis and asthma test for children (CARATKids)-a prospective multicenter study. Pediatr Allergy Immunol 2014; 25: 173-179.
Burnay E, Cruz-Correia R, Jacinto T, Sousa AS, Fonseca J,. Challenges of a mobile application for asthma and allergic rhinitis patient enablement-interface and synchronization. Telemed J e-health 2013; 19: 13-18.
Braido F, Baiardini I, Stagi E, Scichilone N, Rossi O, Lombardi C, et al., RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment. Allergy 2012; 67: 1443-1450.
Bright TJ, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux RR, et al., Effect of clinical decision-support systems: a systematic review. Ann Intern Med 2012; 157: 29-43.
Jaspers MW, Smeulers M, Vermeulen H, Peute LW,. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc 2011; 18: 327-334.
lavel R, Bousquet J, Andre C,. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998; 53: 493-498.
Reips UD, Funke F,. Interval-level measurement with visual analogue scales in Internet-based research: VAS Generator. Behav Res Methods 2008; 40: 699-704.
Dunton GF, Dzubur E, Kawabata K, Yanez B, Bo B, Intille S,. Development of a smartphone application to measure physical activity using sensor-assisted self-report. Front Publ Health 2014; 2: 12.
Shiffman S, Stone AA, Hufford MR,. Ecological momentary assessment. Ann Rev Clin Psychol 2008; 4: 1-32.
Radzuweit M, Lechner U,. Introducing tablet computers into medical practice: design of mobile apps for consultation services. Health Technol Assess 2014; 4: 31-41.
Lluch M,. Strategic Intelligence Monitor on Personal Health Systems phase 2 (SIMPHS 2) Evidence consolidation Report on best practices and key drivers of success, JRC-IPTS. 2012. Available from: https://ec.europa.eu/jrc/sites/default/files/jrc73069.pdf.
Dubey G,. Les nouvelles technologies en autonomie et santé: un déplacement des frontières de la connaissance Ann Mines. 2014(82-88).
Beusart-Zéphir M, Eklin P, Pelayo S, Beuscart R,. The human factors engineering approach to biomedical informatics projects: state of the art, results, benefits and challenges. Yearb Med Inform 2007: 109-27.
Wang K, Wang C, Xi L, Zhang Y, Ouyang Y, Lou H, et al., A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone. Int Arch Allergy Immunol 2014; 163: 51-58.
de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R,. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev 2012; 12: CD007459.
Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J,. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev 2013; 12: CD007458.
Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, et al., Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 2014; 7: 6.
Council conclusions on Healthy Ageing across the Lifecycle. 3206th Employment, social policy, ehalth and consumer affairs Council meeting. Brussels, 7 December 2012. http://wwwconsiliumeuropaeu/uedocs/cms-data/docs/pressdata/en/lsa/134097pdf. 2012.
Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A, et al., Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliamen. Allergy 2013; 68: 555-561.
Frew AJ, Dubuske L, Keith PK, Corrigan CJ, Aberer W, Fischer vW-DK,. Assessment of specific immunotherapy efficacy using a novel placebo score-based method. Ann Allergy Asthma Immunol 2012; 109: 342-347.
Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al., Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
Beggs PJ, Bambrick HJ,. Is the global rise of asthma an early impact of anthropogenic climate change? Environ Health Perspect 2005; 113: 915-919.
Hollins PD, Kettlewell PS, Atkinson MD, Stephenson DB, Corden JM, Millington WM, et al., Relationships between airborne fungal spore concentration of Cladosporium and the summer climate at two sites in Britain. Int J Biometeorl 2004; 48: 137-141.
Deak AJ, Makra L, Matyasovszky I, Csepe Z, Muladi B,. Climate sensitivity of allergenic taxa in Central Europe associated with new climate change related forces. Sci Total Environ 2012; 442C: 36-47.
de WL, Hiemstra PS,. The effect of climate change on pollen allergy in the Netherlands. Ned Tijdschr Geneeskd 2009; 153: A1410.
Emberlin J, Detandt M, Gehrig R, Jaeger S, Nolard N, Rantio-Lehtimaki A,. Responses in the start of Betula (birch) pollen seasons to recent changes in spring temperatures across Europe. Int J Biometeorl 2002; 46: 159-170.
Fitter AH, Fitter RS,. Rapid changes in flowering time in British plants. Science 2002; 296: 1689-1691.
Stach A, Emberlin J, Smith M, Adams-Groom B, Myszkowska D,. Factors that determine the severity of Betula spp. pollen seasons in Poland (Poznan and Krakow) and the United Kingdom (Worcester and London). Int J Biometeorl 2008; 52: 311-321.
Smith M, Emberlin J, Stach A, Czarnecka-Operacz M, Jenerowicz D, Silny W,. Regional importance of Alnus pollen as an aeroallergen: a comparative study of Alnus pollen counts from Worcester (UK) and Poznan (Poland). AAEM 2007; 14: 123-128.
Garcia-Mozo H, Galan C, Jato V, Belmonte J, de lGC, Fernandez D, et al., Quercus pollen season dynamics in the Iberian peninsula: response to meteorological parameters and possible consequences of climate change. AAEM 2006; 13: 209-224.
Emberlin J, Mullins J, Corden J, Jones S, Millington W, Brooke M, et al., Regional variations in grass pollen seasons in the UK, long-term trends and forecast models. Clin Exp Allergy 1999; 29: 347-356.
Wayne P, Foster S, Connolly J, Bazzaz F, Epstein P,. Production of allergenic pollen by ragweed (Ambrosia artemisiifolia L.) is increased in CO2-enriched atmospheres. Ann Allergy Asthma Immunol 2002; 88: 279-282.
Ziska LH, Gebhard DE, Frenz DA, Faulkner S, Singer BD, Straka JG,. Cities as harbingers of climate change: common ragweed, urbanization, and public health. J Allergy Clin Immunol 2003; 111: 290-295.
Frei T, Gassner E,. Climate change and its impact on birch pollen quantities and the start of the pollen season an example from Switzerland for the period 1969-2006. Int J Biometeorl 2008; 52: 667-674.
Ahlholm JU, Helander ML, Savolainen J,. Genetic and environmental factors affecting the allergenicity of birch (Betula pubescens ssp. czerepanovii [Orl.] Hamet-ahti) pollen. Clin Exp Allergy 1998; 28: 1384-1388.
Molfino NA, Slutsky AS, Zamel N,. The effects of air pollution on allergic bronchial responsiveness. Clin Exp Allergy 1992; 22: 667-672.
Behrendt H, Becker WM, Fritzsche C, Sliwa-Tomczok W, Tomczok J, Friedrichs KH, et al., Air pollution and allergy: experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 1997; 3: 69-74.
D'Amato G,. Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseases. Allergy 2002; 57 (Suppl 72): 30-33.
Shea KM, Truckner RT, Weber RW, Peden DB,. Climate change and allergic disease. J Allergy Clin Immunol 2008; 122: 443-453.
de-Manuel-Keenoy E, David M, Mora J, Prieto L, Domingo C, Orueta J, et al., Activation of Stratification Strategies and Results of the interventions on frail patients of Healthcare Services (ASSEHS) DG Sanco Project No. 2013 12 04. Eur Geriatr Med 2014; 5: 342-346.
